Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Belfius Equities Global Health Care C Cap

Ranked 7 out of 18 in - Pharmaceuticals & Health Care over 12 months
All calculations are in EUR unless stated

Objective

The fund invests mainly in stocks from the Health Care sector (medical equipment, pharmaceuticals, biotechnology, etc.) listed on the exchanges of the three major regions (Asia, Europe, and America).

Showing fund performance in Belgium View performance globally

Performance

Pharmaceuticals & Health Care over : 30/09/2016 - 30/09/2017

Total Return

Quarterly Performance

to 29/09/2017 Annual Q1 Q2 Q3 Q4
2017 6.4% 1.8% -0.8%
2016 -5.4% -12.1% 8.1% -0.7% 0.2%
2015 17.8% 21.6% -2.3% -9.7% 9.8%
2014 33.7% 4.6% 5.4% 12.0% 8.3%
2013 29.6% 17.9% 0.9% 2.3% 6.4%
2012 13.2% 5.0% 4.7% 4.9% -1.8%
2011 9.3% -1.5% 5.1% -5.5% 11.8%
2010 9.2% 7.4% -3.0% 0.4% 4.4%
2009 15.6% -4.5% 4.2% 7.1% 8.4%
2008 -19.4% -16.8% -1.0% 8.9% -10.0%
2007 -10.0% -0.5% 0.0% -4.4% -5.4%
2006 1.0% 1.0% -5.7% 7.5% -1.4%
2005 22.8% 2.6% 11.9% 3.7% 3.1%
2004 -2.7% 1.8% 2.9% -4.6% -2.7%
2003 -0.1% -4.9% 6.8% -2.4% 0.7%
2002 -31.4% 0.7% -22.9% -9.3% -2.6%
2001 -9.5% -8.8% 5.5% -7.2% 1.4%
2000 39.3% 9.5% 16.6% 10.2% -0.9%
1999 6.4% 9.1% -2.3% -8.7% 9.4%

Month by Month Performance

Returns Vs Risk

Registered For Sale In

  1. Austria
  2. Belgium
  3. France
  4. Germany
  5. Luxembourg
  6. Netherlands

Fund Info

  • Launch date04/06/1997
  • Share Class size321Mn
  • Base currencyUSD
  • ISIN BE0163900674

Purchase Info

  • Min. initial investment0
  • Min. regular additional investment0

Charges

  • Annual management1.50%

Related News

Pfizer power play: healthcare stars react to $14bn deal

Citywire Selector canvassed sector specialists on what the pharma giant’s latest purchase means for M&A and long-term investments.

Analyst watch: Candriam boosts biotech team

Healthcare specialist Rudi Van den Eynde set to be assisted in drug development knowledge in biotechnology space.

Biotech star’s team bolstered with new hire

Candriam Investors Group appoints senior analyst to join Citywire A-rated manager's specialist healthcare team.

Dexia AM strengthens healthcare funds team

Franco-Belgian investment firm appoints biotech specialist as it seeks to broaden knowledge on healthcare fund.

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).